---
layout: minimal-medicine
title: Omapatrilat
---

# Omapatrilat
### Generic Name
Omapatrilat

### Usage
Omapatrilat is an antihypertensive medication, meaning it lowers blood pressure.  It was investigated for use in managing hypertension (high blood pressure) and heart failure.  However, it never received FDA approval due to safety concerns.  The primary intended use was to reduce blood pressure and improve symptoms in individuals with these conditions. Secondary uses were not established due to the discontinuation of its development.

### Dosage
Because omapatrilat was never approved for market use, there are no established dosage recommendations for adults or children.  Information regarding different formulations (tablet, syrup, injection) and administration guidelines is unavailable due to its lack of approval.

### Side Effects
Since omapatrilat didn't receive FDA approval, a comprehensive list of all side effects based on large-scale clinical trials is unavailable.  However, the safety concerns that led to the discontinuation of its development were primarily related to an increased risk of angioedema (swelling under the skin, particularly around the face, lips, tongue, or throat).  Other potential side effects likely would have included those common to ACE inhibitors and NEP inhibitors, such as:

* Dizziness
* Cough
* Fatigue
* Headache
* Nausea
* Hyperkalemia (high potassium levels)


**Important:**  If any adverse effects occur, immediately consult a healthcare professional.  This list is not exhaustive and does not replace professional medical advice.

### How it Works
Omapatrilat works by inhibiting two enzymes: angiotensin-converting enzyme (ACE) and neutral endopeptidase (NEP).  ACE inhibition reduces the production of angiotensin II, a powerful vasoconstrictor (a substance that narrows blood vessels).  This leads to vasodilation (widening of blood vessels), reducing blood pressure.  NEP inhibition prevents the breakdown of substances that promote vasodilation and fluid excretion by the kidneys, further lowering blood pressure.  In simpler terms, it helps relax blood vessels and remove excess fluid from the body, thus lowering blood pressure.

### Precautions
Due to its lack of approval, comprehensive precaution information is unavailable.  However, based on its mechanism of action, potential precautions would include:

* **Contraindications:**  Individuals with a history of angioedema, particularly related to ACE inhibitors, would likely be contraindicated.
* **Drug Interactions:** Omapatrilat likely interacts with other medications, particularly those affecting the renin-angiotensin-aldosterone system (RAAS) or potassium levels.
* **Special Populations:**  Pregnant women, breastfeeding mothers, and individuals with impaired kidney or liver function would require careful monitoring.  Children's dosage and safety would not be established.


**Important:**  Never take omapatrilat without explicit direction from a healthcare professional.

### FAQs

**Q: Is omapatrilat still available?**
A: No, omapatrilat was never approved for market use and is therefore unavailable.

**Q: Why wasn't omapatrilat approved?**
A:  The primary reason for its non-approval was an increased risk of angioedema compared to other similar medications.

**Q: What are the alternatives to omapatrilat?**
A: Many other medications effectively treat hypertension and heart failure.  Your doctor can recommend appropriate alternatives based on your individual needs.

**Q: Where can I find more information about omapatrilat?**
A:  Due to its lack of approval and discontinuation of development, reliable and detailed information beyond what is presented here may be limited.  Consult a healthcare professional or refer to archived research articles.


**Disclaimer:**  This information is for educational purposes only and should not be considered medical advice. Always consult with a qualified healthcare professional before making any decisions about your health or treatment.
